Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Check source scope before reading a dose
GlobalRPh RX List - Jantoven
Product / population
Adult product-specific renal information; not a complete prescribing regimen.
Renal method
INR-guided dosing; no numeric renal-function dose bands.
Source revision
September 2017 on retrieved RX page
Retrieved
2026-09-07
Local review status
Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.
GlobalRPh-hosted RX List · Adult product-specific renal information; not a complete prescribing regimen.
Renal method: INR-guided dosing; no numeric renal-function dose bands. Source date: September 2017 on retrieved RX page Retrieved: 2026-09-07
Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
No adjustment within stated limits. This does not establish dosing outside the studied renal range or population.
Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.
Renal dosing, restrictions and evidence limits
The JANTOVEN source does not require an automatic renal-failure dose reduction, but requires more frequent INR monitoring with compromised renal function. Dose and target INR remain individualized to response and indication. This is not a fixed-dose recommendation or a statement that kidney disease carries no bleeding risk.
RDM34-rxlist-jantoven-drug-C1 · Source locator: Dosage and administration: individualized dosing and renal impairment.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.